NGEN Stock Summary and Trading Ideas (Nervgen Pharma Corp. | NASDAQ:NGEN)

NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.

What symbol and exchange does Nervgen Pharma Corp. shares trade?

Nervgen Pharma Corp. trades on the NASDAQ stock market under the symbol NGEN.

What is Nervgen Pharma Corp. stock price doing today?

As of October 6, 2026, NGEN stock price declined to $1.80 with 165,468 million shares trading.

What is Nervgen Pharma Corp.'s Beta?

NGEN has a beta of 1.41, meaning it tends to be more sensitive to market movements. NGEN has a correlation of 0.04 to the broad based SPY ETF.

How much is Nervgen Pharma Corp. worth?

NGEN has a market cap of $193.54 million. This is considered a Micro Cap stock.

What are the top ETFs holding Nervgen Pharma Corp.?

The top ETF exchange traded funds that NGEN belongs to (by Net Assets): GWX, IBRN.

What are the support and resistance levels for Nervgen Pharma Corp. (NGEN)?

NGEN support price is $1.73 and resistance is $1.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NGEN shares will trade within this expected range on the day.